Cancer chemoprevention through dietary flavonoids: what's limiting?

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Flavonoids, polyphenols from plants, exhibit chemo-preventive and cytotoxic properties against various cancers through multiple mechanisms.
• Preclinical and clinical data support the potential of specific flavonoids in cancer therapy.

Purpose of the Study:

• To review the significant challenges limiting the clinical application of flavonoids.
• To summarize current efforts and strategies aimed at overcoming these limitations.

Main Methods:

• Literature review of preclinical and clinical studies on flavonoids and cancer.
• Analysis of challenges in flavonoid isolation, purification, efficacy demonstration, and pharmacokinetics.
• Overview of emerging approaches to enhance flavonoid bioavailability and therapeutic efficacy.

Main Results:

• Key challenges include difficulties in isolating and purifying flavonoids, the lengthy and costly process of demonstrating cancer risk reduction, and significant pharmacokinetic issues like poor bioavailability and drug interactions.
• Despite these hurdles, various innovative strategies are being developed to improve flavonoid delivery and effectiveness.

Conclusions:

• Overcoming the identified challenges is crucial for realizing the full therapeutic potential of flavonoids as chemo-preventive agents.
• Continued research and development of novel approaches will facilitate the clinical integration of flavonoids in cancer treatment and prevention.